Vanishing Bile Duct Syndrome Caused by a Treatment Regimen Including Avacopan for Microscopic Polyangiitis

Mako Hishinuma1, Midori Hasegawa2, Shun Minatoguchi1

  • 1Department of Nephrology, Fujita Health University School of Medicine, Japan.

PubMed

Insights

Avacopan treatment for microscopic polyangiitis led to vanishing bile duct syndrome and liver injury, despite successful vasculitis remission. The patient ultimately died from progressive liver damage.

Area of Science:

  • Hepatology
  • Immunology
  • Nephrology

Background:

  • Microscopic polyangiitis is a severe autoimmune vasculitis.
  • Avacopan is a novel treatment for ANCA-associated vasculitis.
  • Drug-induced liver injury is a significant clinical concern.

Purpose of the Study:

  • To report a case of vanishing bile duct syndrome associated with avacopan treatment.
  • To investigate the potential hepatotoxicity of avacopan in a patient with microscopic polyangiitis.
  • To highlight the challenges in managing drug-induced liver injury in elderly patients.

Main Methods:

  • Case report of an 81-year-old male patient.
  • Treatment with prednisolone, avacopan, and rituximab for microscopic polyangiitis.
  • Monitoring of liver enzymes, liver biopsy, and autopsy findings.

Main Results:

  • Elevated liver enzymes were observed 42 days after initiating avacopan.
  • Liver biopsy confirmed vanishing bile duct syndrome.
  • Autopsy revealed persistent bile ductopenia, liver cell injury, cholestasis, and fibrosis.

Conclusions:

  • Avacopan may be associated with vanishing bile duct syndrome and severe liver injury.
  • Early recognition and discontinuation of the offending agent are crucial.
  • Further research is needed to understand the mechanisms and risk factors for avacopan-induced liver injury.

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
767
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
671
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
317
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
2.9K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
748